Search research articles
Contact Us
Filters
Showing results (1-10 of 191) with videos related to
Page
of 20
Sort By:
Lancet (London, England)
|
January 17, 2015
Shorter treatments for hepatitis C: another step forward?
Graham R Foster
Journal of Viral Hepatitis
|
March 6, 2002
Management of chronic hepatitis C--time for a change?
Graham R Foster
Hepatology (Baltimore, Md.)
|
October 1, 2014
Mutant Ninja viruses
Graham R Foster
Journal of Hepatology
|
May 2, 2016
Reply to: "High mortality during direct acting antiviral therapy for hepatitis C patients with Child's C cirrhosis: Results of the Irish Early Access Programme"
Graham R Foster
The Lancet. Gastroenterology & Hepatology
|
April 14, 2017
Chronic hepatitis C: less of a problem than first thought?
Graham R Foster
Addiction (Abingdon, England)
|
September 12, 2008
Injecting drug users with chronic hepatitis C: should they be offered antiviral therapy?
Graham R Foster
Journal of Viral Hepatitis
|
December 29, 2015
The Journal Of Viral Hepatitis 2016
Graham R Foster
Drugs
|
January 30, 2010
Pegylated interferons for the treatment of chronic hepatitis C: pharmacological and clinical differences between peginterferon-alpha-2a and peginterferon-alpha-2b
Graham R Foster
Journal of Hepatology
|
February 5, 2013
Reply to: "usefulness of Lead-In phase in determining risk/benefit of telaprevir treatment in patients with HCV cirrhosis"
Graham R Foster
Expert Opinion on Pharmacotherapy
|
May 13, 2003
Pegylated interferon with ribavirin therapy for chronic infection with the hepatitis C virus
Graham R Foster
Page
of 20
Search research articles
Search
Showing results (1-10 of 191) with videos related to
Sort By:
Page
of 20
Lancet (London, England)
|
January 17, 2015
Shorter treatments for hepatitis C: another step forward?
Graham R Foster
Journal of Viral Hepatitis
|
March 6, 2002
Management of chronic hepatitis C--time for a change?
Graham R Foster
Hepatology (Baltimore, Md.)
|
October 1, 2014
Mutant Ninja viruses
Graham R Foster
Journal of Hepatology
|
May 2, 2016
Reply to: "High mortality during direct acting antiviral therapy for hepatitis C patients with Child's C cirrhosis: Results of the Irish Early Access Programme"
Graham R Foster
The Lancet. Gastroenterology & Hepatology
|
April 14, 2017
Chronic hepatitis C: less of a problem than first thought?
Graham R Foster
Addiction (Abingdon, England)
|
September 12, 2008
Injecting drug users with chronic hepatitis C: should they be offered antiviral therapy?
Graham R Foster
Journal of Viral Hepatitis
|
December 29, 2015
The Journal Of Viral Hepatitis 2016
Graham R Foster
Drugs
|
January 30, 2010
Pegylated interferons for the treatment of chronic hepatitis C: pharmacological and clinical differences between peginterferon-alpha-2a and peginterferon-alpha-2b
Graham R Foster
Journal of Hepatology
|
February 5, 2013
Reply to: "usefulness of Lead-In phase in determining risk/benefit of telaprevir treatment in patients with HCV cirrhosis"
Graham R Foster
Expert Opinion on Pharmacotherapy
|
May 13, 2003
Pegylated interferon with ribavirin therapy for chronic infection with the hepatitis C virus
Graham R Foster
Page
of 20